EE200000481A - Angiotensiin II 2. tüüpi retseptori agonisti sisaldav farmatseutiline preparaat ja selle kasutamine - Google Patents
Angiotensiin II 2. tüüpi retseptori agonisti sisaldav farmatseutiline preparaat ja selle kasutamineInfo
- Publication number
- EE200000481A EE200000481A EEP200000481A EEP200000481A EE200000481A EE 200000481 A EE200000481 A EE 200000481A EE P200000481 A EEP200000481 A EE P200000481A EE P200000481 A EEP200000481 A EE P200000481A EE 200000481 A EE200000481 A EE 200000481A
- Authority
- EE
- Estonia
- Prior art keywords
- type
- pharmaceutical preparation
- receptor agonist
- preparation containing
- containing angiotensin
- Prior art date
Links
- 102000025309 Type 2 Angiotensin Receptor Human genes 0.000 title 1
- 108010062475 Type 2 Angiotensin Receptor Proteins 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 239000000018 receptor agonist Substances 0.000 title 1
- 229940044601 receptor agonist Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/085—Angiotensins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Vascular Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9800550A SE9800550D0 (sv) | 1998-02-24 | 1998-02-24 | A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof |
| PCT/SE1999/000262 WO1999043339A1 (en) | 1998-02-24 | 1999-02-24 | A pharmaceutical preparation comprising an angiotensin ii type 2 receptor agonist, and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE200000481A true EE200000481A (et) | 2002-02-15 |
Family
ID=20410283
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200000481A EE200000481A (et) | 1998-02-24 | 1999-02-24 | Angiotensiin II 2. tüüpi retseptori agonisti sisaldav farmatseutiline preparaat ja selle kasutamine |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1066048A1 (is) |
| JP (1) | JP2002504516A (is) |
| KR (1) | KR20010041211A (is) |
| CN (1) | CN1291104A (is) |
| AU (1) | AU755949B2 (is) |
| BR (1) | BR9908188A (is) |
| CA (1) | CA2319123A1 (is) |
| EE (1) | EE200000481A (is) |
| HU (1) | HUP0101411A3 (is) |
| ID (1) | ID26639A (is) |
| IL (1) | IL137990A0 (is) |
| IS (1) | IS5594A (is) |
| MX (1) | MXPA00008172A (is) |
| NO (1) | NO20004215L (is) |
| NZ (1) | NZ506188A (is) |
| SE (1) | SE9800550D0 (is) |
| SK (1) | SK11522000A3 (is) |
| WO (1) | WO1999043339A1 (is) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6821953B1 (en) | 1999-12-16 | 2004-11-23 | University Of Southern California | Methods for treating and preventing damage to mucosal tissue |
| AU1793101A (en) * | 1999-12-16 | 2001-06-25 | University Of Southern California | Methods for treating and preventing damage to mucosal tissue |
| WO2002096883A1 (en) | 2001-05-31 | 2002-12-05 | Vicore Pharma Ab | Tricyclic compounds useful as angiotensin ii agonists |
| KR101488812B1 (ko) | 2005-04-12 | 2015-02-02 | 바이코어 파마 아베 | 신규한 비시클릭 안지오텐신 ⅱ 아고니스트 |
| JP5202301B2 (ja) | 2005-04-12 | 2013-06-05 | ヴィコール・ファルマ・アーベー | 新規な三環系アンジオテンシンｉｉアゴニスト |
| DE602006018122D1 (de) | 2005-04-12 | 2010-12-23 | Vicore Pharma Ab | Neue tricyclische angiotensin-ii-agonisten |
| US20080317670A1 (en) * | 2005-12-14 | 2008-12-25 | Ambrx, Inc. | Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides |
| US8835471B2 (en) | 2010-06-11 | 2014-09-16 | Vicore Pharma Ab | Use of angiotensin II agonists |
| EP2455388A1 (en) | 2010-11-23 | 2012-05-23 | LanthioPep B.V. | Novel angiotensin type 2 (AT2) receptor agonists and uses thereof. |
| WO2013158628A1 (en) * | 2012-04-16 | 2013-10-24 | New York University | Modulation of angiotensin ii peceptors for the prevention and treatment of cerebral malaria |
| HK1244232A1 (zh) | 2015-03-02 | 2018-08-03 | 维科尔药物公司 | 用於治疗肺纤维化的血管紧张素ii受体激动剂 |
| WO2017221012A1 (en) | 2016-06-21 | 2017-12-28 | Vicore Pharma Ab | Methods and compositions for preventing or reducing the risk of cancer treatment-related cardiotoxicity |
| GB201818164D0 (en) | 2018-11-07 | 2018-12-19 | Vicore Pharma Ab | New composition |
| JP2022542437A (ja) | 2019-08-02 | 2022-10-03 | ランティオペプ ベスローテン ヴェンノーツハップ | 癌の処置に用いるアンジオテンシン２型（ａｔ２）受容体アゴニスト |
| GB201913603D0 (en) | 2019-09-20 | 2019-11-06 | Vicore Pharma Ab | New compounds |
| WO2021186185A1 (en) | 2020-03-19 | 2021-09-23 | Vicore Pharma Ab | Novel compounds useful in the treatment and/or prevention of a disease, disorder or condition associated with angiotensin ii |
| GB202004094D0 (en) | 2020-03-20 | 2020-05-06 | Vicore Pharma Ab | New compounds and uses |
| GB202006081D0 (en) | 2020-04-24 | 2020-06-10 | Vicore Pharma Ab | New composition |
| GB202006074D0 (en) | 2020-04-24 | 2020-06-10 | Vicore Pharma Ab | New composition |
| GB202006079D0 (en) | 2020-04-24 | 2020-06-10 | Vicore Pharma Ab | New composition |
| GB202013721D0 (en) | 2020-09-01 | 2020-10-14 | Vicore Pharma Ab | New compounds |
| GB202104038D0 (en) | 2021-03-23 | 2021-05-05 | Vicore Pharma Ab | New compounds |
| GB202104033D0 (en) | 2021-03-23 | 2021-05-05 | Vicore Pharma Ab | New compounds |
| WO2022200785A1 (en) | 2021-03-23 | 2022-09-29 | Vicore Pharma Ab | Selective angiotensin ii receptor ligands |
| EP4367110A1 (en) | 2021-07-09 | 2024-05-15 | Vicore Pharma AB | New selective angiotensin ii compounds |
| GB202115303D0 (en) | 2021-10-25 | 2021-12-08 | Vicore Pharma Ab | New formulation |
| GB202201723D0 (en) | 2022-02-10 | 2022-03-30 | Vicore Pharma Ab | New use |
| WO2023152503A1 (en) | 2022-02-10 | 2023-08-17 | Vicore Pharma Ab | Use of buloxibutid for the treatment of idiopathic pulmonary fibrosis |
| KR20250002355A (ko) | 2022-04-06 | 2025-01-07 | 우한 휴먼웰 이노베이티브 드러그 리서치 앤드 디벨롭먼트 센터 리미티드 컴퍼니 | Ａｔ２ｒ 작용제 |
| WO2024133942A1 (en) | 2022-12-22 | 2024-06-27 | Vicore Pharma Ab | A method of treating a patient diagnosed with an interstitial lung disease |
| JP2026502510A (ja) | 2023-01-09 | 2026-01-23 | ヴィコール ファルマ アーベー | 選択的アンジオテンシンｉｉ化合物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5444067A (en) * | 1993-08-30 | 1995-08-22 | Merck & Co., Inc. | Pharmaceutical treatment methods using angiotensin II receptor agonists bearing a thiophene moiety |
| WO1996014060A1 (en) * | 1994-11-04 | 1996-05-17 | Marklund Stefan L | Use of receptor agonists to stimulate superoxide dismutase activity |
| SE9501881D0 (sv) * | 1995-05-19 | 1995-05-19 | Astra Ab | New pharmacological use of AII-receptor antagonists |
| US5834432A (en) * | 1995-06-06 | 1998-11-10 | The University Of Southern California | Use of angiotensin II Type 2 receptor agonists in tissue repair |
| SE9502219D0 (sv) * | 1995-06-19 | 1995-06-19 | Astra Ab | Novel medical use |
-
1998
- 1998-02-24 SE SE9800550A patent/SE9800550D0/xx unknown
-
1999
- 1999-02-24 MX MXPA00008172A patent/MXPA00008172A/es unknown
- 1999-02-24 WO PCT/SE1999/000262 patent/WO1999043339A1/en not_active Ceased
- 1999-02-24 EP EP99908017A patent/EP1066048A1/en not_active Withdrawn
- 1999-02-24 ID IDW20001909A patent/ID26639A/id unknown
- 1999-02-24 AU AU27537/99A patent/AU755949B2/en not_active Ceased
- 1999-02-24 IL IL13799099A patent/IL137990A0/xx unknown
- 1999-02-24 CA CA002319123A patent/CA2319123A1/en not_active Abandoned
- 1999-02-24 BR BR9908188-1A patent/BR9908188A/pt not_active IP Right Cessation
- 1999-02-24 HU HU0101411A patent/HUP0101411A3/hu unknown
- 1999-02-24 SK SK1152-2000A patent/SK11522000A3/sk unknown
- 1999-02-24 NZ NZ506188A patent/NZ506188A/xx unknown
- 1999-02-24 KR KR1020007009295A patent/KR20010041211A/ko not_active Withdrawn
- 1999-02-24 JP JP2000533135A patent/JP2002504516A/ja active Pending
- 1999-02-24 EE EEP200000481A patent/EE200000481A/xx unknown
- 1999-02-24 CN CN99803230A patent/CN1291104A/zh active Pending
-
2000
- 2000-08-21 IS IS5594A patent/IS5594A/is unknown
- 2000-08-23 NO NO20004215A patent/NO20004215L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1291104A (zh) | 2001-04-11 |
| ID26639A (id) | 2001-01-25 |
| AU2753799A (en) | 1999-09-15 |
| IL137990A0 (en) | 2001-10-31 |
| HUP0101411A3 (en) | 2002-11-28 |
| HUP0101411A2 (hu) | 2002-03-28 |
| SK11522000A3 (sk) | 2001-04-09 |
| MXPA00008172A (es) | 2002-06-21 |
| SE9800550D0 (sv) | 1998-02-24 |
| NZ506188A (en) | 2003-04-29 |
| JP2002504516A (ja) | 2002-02-12 |
| BR9908188A (pt) | 2000-10-24 |
| WO1999043339A1 (en) | 1999-09-02 |
| KR20010041211A (ko) | 2001-05-15 |
| EP1066048A1 (en) | 2001-01-10 |
| NO20004215L (no) | 2000-09-18 |
| IS5594A (is) | 2000-08-21 |
| AU755949B2 (en) | 2003-01-02 |
| NO20004215D0 (no) | 2000-08-23 |
| CA2319123A1 (en) | 1999-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE200000481A (et) | Angiotensiin II 2. tüüpi retseptori agonisti sisaldav farmatseutiline preparaat ja selle kasutamine | |
| EE200000232A (et) | Farmatseutiline kompositsioon ja selle kasutamine | |
| PT1019358E (pt) | 3,3-diarilpropilaminas sua utilizacao e sua preparacao | |
| DK1009732T3 (da) | 1-Amino-alkylcyclohexan NMDA receptor antagonister | |
| PT1177178E (pt) | Benzimidazois hetereciclicos substituidos, sua preparacao e aplicacao | |
| NO20012915D0 (no) | Ny farmasöytisk formulering | |
| ATE265850T1 (de) | Ibuprofenhaltige arzneizubereitung | |
| PT1123274E (pt) | Derivados de fenilo substituido, sua preparacao e utilizacao | |
| BR9708400A (pt) | Composição sua preparação e uso | |
| NO20012411D0 (no) | Pyrrolidin-derivater-CCR-3-reseptorantagonister | |
| BRPI9810519B1 (pt) | derivados de 4''-substituìdo-9-desoxo-9a-aza-9a-homoeritromicina a e composição farmacêutica compreendendo os mesmos. | |
| EE04452B1 (et) | Farmatseutiliselt aktiivne morfolinool ja selle kasutamine | |
| ID29247A (id) | Bahan pengatur fungsi reseptor retinoid | |
| EE200000621A (et) | Pikornaviirusevastased ühendid, nende valmistamine ja kasutamine | |
| DE59915033D1 (de) | Pharmazeutische Zubereitung | |
| ID24726A (id) | Antagonis-antagonis reseptor trombin | |
| NO20010089D0 (no) | Farmasöytisk levotyroksinpreparat | |
| ID24162A (id) | Antagonis-antagonis reseptor vitronektin | |
| EE03387B1 (et) | Kombineeritud ravimpreparaat, selle kasutamine ja meetod selle valmistamiseks | |
| EE04260B1 (et) | Farmatseutiline kompositsioon, selle valmistamisemeetod ja kasutamine | |
| AU5861900A (en) | Receptor agonists and antagonists | |
| BR9710568A (pt) | Composi- o farmac-utica contendo um antagonista 5Hht2c e um antagonista d2 | |
| IT1291823B1 (it) | Composti pseudo-peptidici, loro preparazione ed uso in formulazioni farmaceutiche | |
| FI971528A7 (fi) | Pyrrolyylitetrahydrobentsokinoksaliinidionit, niiden valmistus ja käyt tö glutamaattireseptoriantagonisteina | |
| AU2003202455A1 (en) | A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof |